Back
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Speed of Cord Blood Unit Provision
Granulocytes to Support Cord Blood Transplants
Flexibility for Urgent Cases- Cord Blood Bank Approach
Treosulfan-Based Conditioning Regimen for Cord Blood Transplantation
Cord Blood Transplantation – Novel Approaches
Welcome to Cord Blood Connect
Aligning Transplant Centers and Cord Blood Banks
Cord Blood Transplantation – Latest Advances
Aligning Transplant Centers and Cord Blood Banks
Cord Blood Support - Services Offered by Registries
Hematopoietic Stem Cell Transplants in the Hispanic Community
Immune Reconstitution after Cord Blood Transplantation
Outcomes of HLA Identical HSCT in Patients with Sickle Cell Disease
US BMT CTN Trial
Mid-Day Forum - Translating Cord Blood Innovation Outside of Academia
Advances in the Treatment of Sickle Cell Disease
Diversity in Collections Transplant Rates and Family Banking
Supporting Diversity through Public Cord Blood Banking
Clinical Development of Omidubicel
Cord Blood Transplantation – Novel Approaches
Diversity and Private Banking
Curative Therapies for Sickle Cell Disease
Cord Blood Transplantation – Latest Advances
Abatacept-Based GVHD Prophylaxis in RIC Transplants for Sickle Cell Disease
Cord Blood Expansion with UM171
Results from a Randomized Trial of Dilanubicel
Omidubicel Facilitates Umbilical Cord Blood Engraftment in Patients with Sickle Cell Disease
Indication and Results of Cord Blood Transplant Compared to Haplo-Identical Transplant
Intermediate Intensity Double Unit Cord Blood Transplantation without Ex Vivo Expansion
Status of Mesenchymal Cell Technology
Mesenchymal Stromal Cells for Chronic Lung Disease of Prematurity
Interactions Between MSC and Macrophages
HCT-MSC in Children with Autism Spectrum Disorder and Cerebral Palsy
Comprehensive MSC Characterization for Correlative Prediction of Function
Developing Anti-COVID-19 Therapies from Birthing Tissues and Cord Blood
Mesenchymal Stromal Cells for Chronic Lung Disease of Prematurity
Product Lifecycle Potency Assays to Clinical Trials
Cord Blood-Derived MSCs and MSC-Exosomes
Impact of COVID-19 Pandemic on Hematopoietic Cell Transplantation
The Quest Toward a Rapid Robust and Validated Stem Cell Potency Assay
Why MSC Manufacturing Matters Regenerative Medicine Commercialization
Remstemcel-L for Pediatric Acute Steroid Refractory GVHD a Meta-Analysis
MSCs for Neonatal Hypoxic-Ischemic Encephalopathy
Umbilical Cord Blood Infusion Reactions
Biology of COVID-19 in Pregnancy and Neonates
Status of Mesenchymal Cell Clinical Trials
Targeting Neuroinflammation with Human Umbilical Cord Tissue-Derived M S Cells
Status of Mesenchymal Cell Clinical Trials
Regenerative Medicine and Immunotherapies
COVID-19 Impact on Banking and Opportunities for Treatment
Regenerative Medicine and Immunotherapies
An Update on Our Quest Toward a Rapid Robust and Validated Stem Cell Potency Assay
Presidents Session Ethics Legislation and Regulation
Banking Cord Blood in the Era of COVID-19
Single UM171-Expanded Cord Blood Transplants
Cord Blood CAR NK Cells for Cancer Immunotherapy
Hydrocortisone-Treated DUOC-01 Experimental Autoimmune Encephalomyelitis
Cord Blood-Derived Virus-Specific T-Cells
COVID-19 Impact on Banking and Opportunities for Treatment
Presidents Closing Comments
Cord Blood CAR NK Cells for Cancer Immunotherapy
Product Lifecycle Potency Assays to Clinical Trials
Overview of Clinical Trials Using Perinatal Cells
An Update on Our Quest Toward a Rapid Robust and Validated Stem Cell Potency Assay
No items found.